March 2015

Effective management of COPD can improve quality of life for patients and help reduce rehospitalizations.

Cyramza, manufactured by Eli Lilly and Company, is an angiogenesis inhibitor indicated for the treatment of patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after treatment with prior fluoropyrimidine- or platinum-containing chemotherapy.

Pharmacists play a vital role in chronic disease management.

Patients who received ampicillin and ceftriaxone were less likely to have new onset renal failure.

There is tremendous momentum and excitement in the pharmacy community surrounding "provider" status.